Tower Research Capital LLC (Trc) Immunic, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Immunic, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,925 shares of IMUX stock, worth $4,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,925
Previous 16,974
76.88%
Holding current value
$4,239
Previous $18,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding IMUX
# of Institutions
70Shares Held
56.2MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$9.62 Million0.47% of portfolio
-
Avidity Partners Management LP Dallas, TX8.27MShares$8.93 Million0.84% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.88 Million1.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$6.04 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.51 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $33M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...